Siting Goh

PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity

P. Ricciardi-Castagnoli, Je Lin Sieow, Valerie Chew, 2016, Oncoimmunology.

Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy

R. Holt, L. Boon, A. Chopra, 2020, Frontiers in Immunology.

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma

B. Au, J. Connolly, P. Chow, 2020, Journal for ImmunoTherapy of Cancer.

Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies

T. Lim, J. Yeong, M. Hong, 2021, Cancers.

Approaches for Handling Immunopathological and Clinical Data Using Deep Learning Methodology: Multiplex IHC/IF Data as a Paradigm

Siting Goh, Yueda Chua, Justina Lee, 2021, Histopathology and Liquid Biopsy [Working Title].

CD38 is a good predictor of anti-PD-1 immunotherapy responsiveness in hepatocellular carcinoma

P. Chow, E. Newell, S. Choo, 2019, bioRxiv.

Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin’s Lymphoma

C. Ong, J. Chiang, S. Lim, 2023, Hematology Reports.